Thanks Askier. I am rather hoping that if I am right on the XBI, biotechs might be the next movers. But there are just so many and a lot of them seem to do nothing but gobble up funds.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
